Tags Archive Navigation
icon
-
Media ReleaseNovartis Scemblix® granted FDA Priority Review for the treatment of adults with newly diagnosed CML
-
StoryGiving voice to people with a misunderstood disease
-
StoryFacing the fear of breast cancer recurrence
-
Landing PageMy Cancer. My Words.
-
StoryInnovation fueled by compassion
-
StoryQ&A: Addressing unmet needs for people living with PNH, a rare and chronic blood disorder
-
StoryWhen you think of the word ‘cancer’, what are the first words that spring to mind?
-
StoryBreaking down barriers for patients with sickle cell disease
-
StoryDemystifying the science of myelodysplastic syndromes
-
Media ReleaseNovartis signs new initial agreement with BioNTech to support fill and finish of the mRNA Pfizer-BioNTech COVID-19 vaccine
-
Media ReleaseNovartis Cosentyx® builds on its axSpA leadership with US label update for dosing flexibility in ankylosing spondylitis
-
Landing PageDiseases